Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q2 2026 | 1 | -$0.85 | -$0.85 | -$0.85 |
| Q3 2026 | 1 | -$0.82 | -$0.82 | -$0.82 |
| Q4 2026 | 1 | -$0.96 | -$0.96 | -$0.96 |
| Q1 2027 | 1 | -$0.89 | -$0.89 | -$0.89 |
| Q2 2027 | 1 | -$0.80 | -$0.80 | -$0.80 |
HeartSciences Inc. last posted its earnings results on Monday, December 15th, 2025. The company reported $-0.85 earnings per share for the quarter, topping analysts' consensus estimates of $-0.9 by $0.05. The company had revenue of 2.42 K for the quarter and had revenue of 4.35 K for the year. HeartSciences Inc. has generated $-9 earnings per share over the last year ($-9.34 diluted earnings per share) and currently has a price-to-earnings ratio of -0.91. HeartSciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/15/2025 | Q2 2026 | -$0.90 | -$0.85 | 0.05 | $1.20 K | $2.42 K |
| 09/11/2025 | Q1 2026 | -$2.41 | -$1.58 | 0.83 | $950 | $1.90 K |
| 07/24/2025 | Q4 2025 | -$2.51 | -$1.88 | 0.63 | $50.00 K | $4.35 K |
| 03/13/2025 | Q3 2025 | -$2.53 | -$2.57 | -0.04 | $550.00 K | $0 |
| 12/16/2024 | Q2 2025 | -$2.30 | -$2.27 | 0.03 | $400.00 K | $0 |
| 09/12/2024 | Q1 2025 | -$2.46 | -$2.64 | -0.18 | $200.00 K | $0 |
| 07/29/2024 | Q4 2024 | -$3.50 | -$2.73 | 0.77 | $50.00 K | $0 |
| 03/14/2024 | Q3 2024 | -$0.06 | -$3.06 | -3 | N/A | $14.70 K |
| 12/14/2023 | Q2 2024 | -$0.12 | -$15.98 | -15.86 | N/A | $3.90 K |
| 09/14/2023 | Q1 2024 | -$0.14 | -$13.23 | -13.09 | N/A | $0 |
| 07/18/2023 | Q4 2023 | N/A | -$16.47 | N/A | N/A | $0 |
| 03/16/2023 | Q3 2023 | -$0.16 | -$16.47 | -16.31 | N/A | $1.95 K |
| 12/15/2022 | Q2 2023 | -$0.33 | -$22.39 | -22.06 | N/A | $0 |
| 09/12/2022 | Q1 2023 | -$28.00 | -$30.55 | -2.55 | N/A | $3.20 K |
| 07/29/2022 | Q4 2022 | N/A | -$64.04 | N/A | N/A | $4.15 K |
| 01/31/2022 | Q3 2022 | N/A | -$37.27 | N/A | N/A | $2.74 K |
| 10/30/2021 | Q2 2022 | N/A | -$31.23 | N/A | N/A | $0 |
| 07/31/2021 | Q1 2022 | N/A | -$15.14 | N/A | N/A | $7.48 K |
| 04/29/2021 | Q4 2021 | N/A | -$25.70 | N/A | N/A | $14.95 K |
In the previous quarter, HeartSciences Inc. (:HSCS) reported $-0.85 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.9 by $0.05.
The conference call for HeartSciences Inc.'s latest earnings report can be listened to online.
The conference call transcript for HeartSciences Inc.'s latest earnings report can be read online.
HeartSciences Inc. (:HSCS) has a recorded annual revenue of $4.35 K.
HeartSciences Inc. (:HSCS) has a recorded net income of $-8,765,229.HeartSciences Inc. has generated $-9.34 earnings per share over the last four quarters.
HeartSciences Inc. (:HSCS) has a price-to-earnings ratio of -0.91 and price/earnings-to-growth ratio is -0.05.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED